Medical Equipment

Enzyme Immunoassay Market Insights Highlighting Opportunities and Drivers Supporting Growth to 2030

March 12, 2026March 12, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Enzyme Immunoassay Market In 2026 And What Value Is Projected For 2030?

The enzyme immunoassay market size has experienced significant expansion in recent years. This market is projected to expand from $21.5 billion in 2025 to $23.09 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.4%. Historically, this expansion was driven by factors such as the restricted access to automated EIA systems, the dependence on manual microplate readers, the developing clinical laboratory infrastructure, a rising incidence of chronic and infectious conditions, and the use of traditional reagents and kits.

The enzyme immunoassay market is anticipated to experience substantial expansion over the upcoming years. It is projected to reach $30.37 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. This expansion during the projected period can be ascribed to advancements in fully automated EIA analyzers, the spread of personalized medicine and precise diagnostics, greater integration of laboratory information systems, an increase in the uptake of software and data analysis tools, and increasing demand from scholarly and scientific establishments. Key patterns expected during this forecast timeframe encompass the increasing implementation of automated EIA analyzers, a rise in therapeutic drug monitoring applications, enhanced utilization of multiplex testing and high-throughput assays, the broadening of oncology and infectious disease testing, and an amplified emphasis on laboratory data integration and operational efficiency.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25763&type=smp

What Drivers Are Influencing The Enzyme Immunoassay Market?

The increasing prevalence of infectious diseases is anticipated to drive expansion in the enzyme immunoassay market. These diseases are conditions caused by detrimental microorganisms like bacteria, viruses, fungi, or parasites, capable of human-to-human transmission. The challenge of infectious diseases is escalating due to antimicrobial resistance, complicating the treatment of common infections and resulting in longer illnesses, higher healthcare expenses, and increased fatalities. Enzyme immunoassays offer significant diagnostic value for infectious diseases, facilitating precise and sensitive detection of antigens or antibodies in patient samples, which supports early detection, efficient tracking, and prompt management of conditions such as HIV, hepatitis, and influenza. An illustration of this is the data from April 2025 by the Minnesota Department of Health, a US-based government entity, showing that HIV cases among males aged 35 to 39 climbed from 10% in 2023 to 17% in 2024, highlighting a significant rise in this demographic’s share of total cases. Consequently, the expanding challenge posed by infectious diseases is propelling the growth of the enzyme immunoassay market.

What Are The Key Segments Of The Enzyme Immunoassay Market?

The enzyme immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End-Use: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, Other End-Uses

Subsegments:

1) By Reagents And Kits: Antibodies, Antigens, Substrates, Buffers And Stabilizers

2) By Analyzers Or Instruments: Fully Automated EIA Analyzers, Semi-Automated EIA Systems, Microplate Readers, Washers And Incubators

3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information System Integration Tools, Instrument Calibration And Validation Services, Technical Support And User Training

What Key Trends Are Influencing The Development Of The Enzyme Immunoassay Market?

Leading companies operating within the enzyme immunoassay market are prioritizing the introduction of innovative enzyme immunoassay (EIA) solutions, such as fully automated enzyme immunoassays, to enhance diagnostic precision, minimize manual errors, and improve workflow efficiency in clinical laboratories. Fully automated enzyme immunoassays are defined as diagnostic systems that autonomously carry out the entire testing process, thereby boosting the speed, accuracy, and consistency of laboratory results. For instance, in July 2024, Fujirebio Holdings Inc., a Japan-based in vitro diagnostics (IVD) company, unveiled the fully automated Lumipulse G GFAP assay for research use only (RUO), thereby expanding its portfolio of neuro-biomarkers. This RUO chemiluminescent enzyme immunoassay measures glial fibrillary acidic protein (GFAP) in human plasma and serum utilizing the LUMIPULSE G platform, delivering results in just 35 minutes. It functions as an astrocytic biomarker implicated in conditions such as multiple sclerosis, Alzheimer’s and Parkinson’s diseases, stroke, and traumatic brain injury. This assay further strengthens Fujirebio’s growing neuro menu, which already includes NfL, pTau217, and sTREM2, enabling comprehensive neurodegenerative disease profiling on a single automated system.

Who Are The Leading Companies Operating In The Enzyme Immunoassay Market?

Major companies operating in the enzyme immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company (BD), PerkinElmer Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc., MyBioSource Inc., Boster Biological Technology, Hycult Biotech, Calbiotech Inc.

Read the full enzyme immunoassay market report here:

https://www.thebusinessresearchcompany.com/report/enzyme-immunoassay-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Enzyme Immunoassay Market?

North America was the largest region in the enzyme immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Enzyme Immunoassay Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25763&type=smp

Browse Through More Reports Similar to the Global Enzyme Immunoassay Market 2026, By The Business Research Company

Enteral Feeding Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-feeding-devices-global-market-report

Enteral Feeding Formula Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-feeding-formula-global-market-report

Enteral Nutrition Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-nutrition-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795